Many cationic amphiphilic (phospholipidosis-inducing) drugs (CADs) accumulate in tissues following repeated dosing in preclinical models, and this is sometimes associated with dose-limiting toxicities. Plasma drug levels cannot be used to estimate tissue accumulation of CADs since it occurs in tissues despite stabilization of plasma levels. Severe myopathy was found in skeletal muscles of rats during the initial safety evaluation of a dopamine D3 receptor antagonist, PNU-177864, and was associated with phospholipidosis in numerous tissues. The myopathy was observed only when plasma levels of PNU-177864 remained essentially constant throughout the 24-hour dosing period. A repeat dose drug distribution study using whole body autoradiography demonstrated that drug-related material did not accumulate in skeletal muscle or other tissues following repeated doses at levels considered within the therapeutic range and showing toxicokinetic profiles acceptable for further development. These observations provided support for the continued development of and longer-term toxicity studies with this candidate compound.
Costa-Jussà, F.R., Corrin, B., and Jacobs, J.M. (1984). Amiodarone lung toxicity: A human and experimental study. J Pathol143, 73—9.
2.
Dean, R.T., Jessup, W., and Roberts, C.R. (1984). Effects of exogenous amines on mammalian cells, with particular reference to membrane flow. Biochem J217, 27—40.
3.
Fardeau, M., Tome, F.M.S., and Simon, P. (1979). Muscle and nerve changes induced by perhexiline maleate in man and mice. Muscle Nerve2, 24—36.
4.
Finbloom, D.S., Silver, K., Newsome, D.A., and Gunkel, R. (1985). Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol12, 692—4.
Hasilik, A., and Neufeld, E.F. (1980). Biosynthesis of lysosomal enzymes in fibroblasts . J Biol Chem255, 4937—45.
7.
Hein, L., Lüllmann-Rauch, R., and Mohr, K. (1990). Human accumulation potential of xenobiotics: potential of catamphiphilic drugs to promote their accumulation via inducing lipidosis or mucopolysaccharidosis. Xenobiotica20, 1259—67.
8.
Heyneman, C.A., and Reasor, M.J. (1986). Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels. J Pharmacol Exp Thera236, 55— 9.
9.
Horn, J.W., Jensen, C.B., White, S.L., Laska, D.A., Novilla, M.N., Giera, D.D., and Hoover, D.M. (1996). In vitro and in vivo ultrastructural changes induced by macrolide antibiotic LY281389. Fundam Appl Toxicol32, 205—16.
10.
Hostetler, K.Y. (1984). Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs. Fed Proceed43, 2582—5.
11.
Kaloyanides, G.J., and Pastoriza-Munoz, E. (1980). Aminoglycoside nephrotoxicity . Kidney Int18, 571—82.
12.
Kannan, R., Sarma, J.S.M., Guha, M., and Venkataraman, K. (1989). Tissue drug accumulation and ultrastructural changes during amiodarone administration in rats. Fundam Appl Toxicol13, 793—803.
13.
Kannan, R., Sarma, J.S.M., Guha, M., and Venkataraman, K. (1991). Amiodarone toxicity. II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats. Fundam Appl Toxicol16, 103—9.
14.
Kumamoto, T., Araki, S., Watanabe, S., Ikebe, N., and Fukuhara, N. (1989). Experimental chloroquine myopathy: Morphological and biochemical studies. Eur Neurol29, 202—7.
15.
Nucci, A., Queiroz, L.S., and Samara, A.M. (1996). Chloroquine neuromyopathy. Clin Neuropathol15, 256—8.
16.
Reasor, M.J. (1989). A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs. Toxicol Appl Pharmacol97, 47—56.
17.
Reasor, M.J., McCloud, C.M., Beard, T.L., Ebert, D.C., Kacew, S., Gardner, M.F., Aldern, K.A., and Hostetler, K.Y. (1996). Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague—Dawley rats. Toxicology106, 139—47.
18.
Reasor, M.J., Ogle, C.L., and Miles, P.R. (1990). Response of rat lungs to amiodarone: Preferential accumulation of amiodarone and desethylamiodarone in alveolar macrophages . Exp Lung Res16, 577—91.
19.
Riva, E., Marchi, S., Pesenti, A., Bizzi, A., Cini, M., Veneroni, E., Tavbani, E., Boeri, R., Bertani, T., and Latini, R. (1987). Amiodarone-induced phospholipidosis: Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone. Biochem Pharmacol36, 3209—14.
20.
Roth, R.F., Itabashi, H., Louie, J., Anderson, T., and Narahara, K.A. (1990). Amiodarone toxicity: Myopathy and neuropathy. Am Heart J119, 1223—5.
21.
Rowland, M., and Tozer, T.N. (1995). Clinical Pharmacokinetics: Concepts and Applications , 3rd ed., pp. 21—46. Williams & Wilkins, Baltimore, MD.
22.
Rudmann, D.G., McNerney, M.E., VanderEide, S.L., Schemmer, J.K., Eversole, R.R., and Vonderfecht, S.L. (2004). Epididymal and systemic phospholipidosis in rats and dogs given the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol32(3), 326—332.
23.
Sauers, L.J., Wierda, D., and Reasor, M.J. (1988). Chlorphentermine suppresses the phosphatidylinositol pathway in concanavalin A-activated mouse splenic lymphocytes. Immunopharm Immunotox10, 1—19.
24.
Schmalbruch, H. (1980). The early changes in experimental myopathy induced by chloroquine and chlorphentermine. J Neuropath Exp Neurol39, 65— 81.
25.
Stäubli, W., Schweizer, W., and Suter, J. (1978). Some properties of myeloid bodies induced in rat liver by an antidepressant drug (maprotiline). Exp Mol Pathol28, 177—95.
26.
Tietze, C., Schlesinger, P., and Stahl, P. (1980). Chloroquine and ammonium ion inhibit receptor-mediated endocytosis of mannose-glycoconjugates by macrophages: Apparent inhibition of receptor recycling. Biochem Biophys Res Commun93, 1—8.
27.
Tolleshaug, H., and Berg, T. (1979). Chloroquine reduces the number of asialoglycoprotein receptors in the hepatocytes plasma membrane. Biochem Pharmacol28, 2919—22.
28.
Whitehouse, L.W., Menzies, A., Mueller, R., and Pontefract, R. (1994). Ketaconazole-induced hepatic phospholipidosis in the mouse and its association with de-N-acetyl ketaconazole. Toxicology94, 81—95.
29.
Wibo, M., and Poole, B. (1974). Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J Cell Biol63, 430—40.
30.
Yano, B.L., Bond, D.M., Novilla, M.N., McFadden, L.G., and Reasor, M.J. (2002). Spinosad insecticide: Subchronic and chronic toxicity and lack of carcinogenicity in Fischer 344 ratsToxicol Sci65, 288—98.
